MedPeer,Inc.

TSE:6095 Voorraadrapport

Marktkapitalisatie: JP¥12.5b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

MedPeerInc Toekomstige groei

Future criteriumcontroles 1/6

MedPeerInc is forecast to grow earnings and revenue by 4.5% and 3.8% per annum respectively. EPS is expected to grow by 4.5% per annum. Return on equity is forecast to be 8.7% in 3 years.

Belangrijke informatie

4.5%

Groei van de winst

4.5%

Groei van de winst per aandeel

Healthcare Services winstgroei15.1%
Inkomstengroei3.8%
Toekomstig rendement op eigen vermogen8.7%
Dekking van analisten

Low

Laatst bijgewerkt18 Sep 2024

Recente toekomstige groei-updates

Recent updates

Market Participants Recognise MedPeer,Inc.'s (TSE:6095) Earnings Pushing Shares 34% Higher

Sep 04
Market Participants Recognise MedPeer,Inc.'s (TSE:6095) Earnings Pushing Shares 34% Higher

Estimating The Intrinsic Value Of MedPeer,Inc. (TSE:6095)

Aug 02
Estimating The Intrinsic Value Of MedPeer,Inc. (TSE:6095)

MedPeerInc's (TSE:6095) Soft Earnings Don't Show The Whole Picture

May 21
MedPeerInc's (TSE:6095) Soft Earnings Don't Show The Whole Picture

Winst- en omzetgroeiprognoses

TSE:6095 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (JPY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
9/30/202717,177930659N/A4
9/30/202616,120842649N/A4
9/30/202515,092745560N/A4
9/30/202415,3681,359541N/A4
6/30/202415,303638N/AN/AN/A
3/31/202415,2614361,1601,284N/A
12/31/202315,006636N/AN/AN/A
9/30/202314,540617495600N/A
6/30/202312,691566N/AN/AN/A
3/31/202311,141594323438N/A
12/31/20229,787712N/AN/AN/A
9/30/20228,452812691853N/A
6/30/20228,3751,004N/AN/AN/A
3/31/20228,0711,1211,0141,238N/A
12/31/20217,8481,226N/AN/AN/A
9/30/20217,4351,2931,1141,361N/A
6/30/20217,1551,183N/AN/AN/A
3/31/20216,8041,1549671,170N/A
12/31/20206,3081,011N/AN/AN/A
9/30/20205,311725759930N/A
6/30/20204,457626N/AN/AN/A
3/31/20203,811510480617N/A
12/31/20193,224418N/AN/AN/A
9/30/20193,045394262374N/A
6/30/20192,842292N/AN/AN/A
3/31/20192,672330346437N/A
12/31/20182,414283N/AN/AN/A
9/30/20182,199206260344N/A
6/30/20182,090-165N/AN/AN/A
3/31/20181,921-262N/A189N/A
12/31/20171,745-327N/AN/AN/A
9/30/20171,559-371N/A179N/A
9/30/201697323N/A4N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 6095's forecast earnings growth (4.5% per year) is above the savings rate (0.3%).

Winst versus markt: 6095's earnings (4.5% per year) are forecast to grow slower than the JP market (8.7% per year).

Hoge groeiwinsten: 6095's earnings are forecast to grow, but not significantly.

Omzet versus markt: 6095's revenue (3.8% per year) is forecast to grow slower than the JP market (4.2% per year).

Hoge groei-inkomsten: 6095's revenue (3.8% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: 6095's Return on Equity is forecast to be low in 3 years time (8.7%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y